InMode Ltd. [NASDAQ: INMD] surged by $2.75 during the normal trading session on Thursday and reaching a high of $26.22 during the day while it closed the day at $26.00. The company report on May 23, 2022 that InMode to Participate at the UBS Healthcare One-on-One Virtual Day.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer and Yair Malca, Chief Financial Officer, will participate at the UBS Healthcare One-on-One Virtual Day on June 1st, 2022. To schedule a meeting, please contact your UBS representative or Miri Segal at firstname.lastname@example.org.
For more information about the event, visit InMode’s investor relations site here.
InMode Ltd. stock has also gained 9.38% of its value over the past 7 days. However, INMD stock has declined by -40.52% in the 3 months of the year. Over the past six months meanwhile, it has lost -69.30% and lost -63.16% year-on date.
The market cap for INMD stock reached $2.20 billion, with 82.97 million shares outstanding and 69.26 million shares in the current float. Compared to the average trading volume of 2.14M shares, INMD reached a trading volume of 3470010 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about InMode Ltd. [INMD]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for INMD shares is $55.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on INMD stock is a recommendation set at 1.30. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Barclays have made an estimate for InMode Ltd. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on May 25, 2021. While these analysts kept the previous recommendation, Needham raised their target price to Buy. The new note on the price target was released on May 18, 2021, representing the official price target for InMode Ltd. stock. Previously, the target price had yet another raise to $28, while UBS analysts kept a Buy rating on INMD stock.
The Average True Range (ATR) for InMode Ltd. is set at 1.95, with the Price to Sales ratio for INMD stock in the period of the last 12 months amounting to 5.82. The Price to Book ratio for the last quarter was 5.35, with the Price to Cash per share for the same quarter was set at 4.72. Price to Free Cash Flow for INMD in the course of the last twelve months was 12.15 with Quick ratio for the last quarter at 8.60.
INMD stock trade performance evaluation
InMode Ltd. [INMD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 9.38. With this latest performance, INMD shares dropped by -0.15% in over the last four-week period, additionally sinking by -69.30% over the last 6 months – not to mention a drop of -39.25% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for INMD stock in for the last two-week period is set at 50.85, with the RSI for the last a single of trading hit 59.05, and the three-weeks RSI is set at 46.11 for InMode Ltd. [INMD]. The present Moving Average for the last 50 days of trading for this stock 30.15, while it was recorded at 23.74 for the last single week of trading, and 56.70 for the last 200 days.
InMode Ltd. [INMD]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and InMode Ltd. [INMD] shares currently have an operating margin of +46.61 and a Gross Margin at +85.01. InMode Ltd.’s Net Margin is presently recorded at +46.14.
Return on Equity for this stock inclined to 49.26, with Return on Assets sitting at 42.61.
InMode Ltd.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 8.60 and a Current Ratio set at 9.10.
Earnings per share (EPS) analysis for InMode Ltd. [INMD] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for INMD. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for InMode Ltd. go to 33.20%.
InMode Ltd. [INMD]: Insider Ownership positions
There are presently around $1,265 million, or 61.40% of INMD stock, in the hands of institutional investors. The top three institutional holders of INMD stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 3,181,662, which is approximately 23.16% of the company’s market cap and around 16.61% of the total institutional ownership; ACADIAN ASSET MANAGEMENT LLC, holding 3,017,257 shares of the stock with an approximate value of $78.45 million in INMD stocks shares; and 1832 ASSET MANAGEMENT L.P., currently with $58.77 million in INMD stock with ownership of nearly 0.004% of the company’s market capitalization.
Positions in InMode Ltd. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 202 institutional holders increased their position in InMode Ltd. [NASDAQ:INMD] by around 13,286,509 shares. Additionally, 181 investors decreased positions by around 10,941,099 shares, while 30 investors held positions by with 24,423,866 shares. The mentioned changes placed institutional holdings at 48,651,474 shares, according to the latest SEC report filing. INMD stock had 58 new institutional investments in for a total of 2,848,421 shares, while 87 institutional investors sold positions of 4,048,612 shares during the same period.